Novo Nordisk A/S (NONOF)
62.50
+6.33
(+11.27%)
USD |
OTCM |
Jan 16, 16:00
Novo Nordisk Market Cap: 277.72B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 929.39B |
| Pfizer Inc. | 145.84B |
| Genmab A/S | 19.83B |
| Ascendis Pharma A/S | 12.58B |
Market Cap Related Metrics
| PE Ratio | 18.21 |
| PS Ratio | 5.963 |
| PEG Ratio | 1.608 |
| Price to Book Value | 10.38 |
| Price to Free Cash Flow | 29.98 |
| Price | 62.50 |
| Earnings Yield | 5.49% |
| PEGY Ratio | 1.292 |
| Operating PE Ratio | 14.06 |
| Normalized PE Ratio | 18.21 |